Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes ... Read more

Financial calendar 2020 ... Read more

University of Virginia Center for Diabetes Technology and Novo Nordisk enter int ... Read more

Novo Nordisk and UNICEF announce new partnership to help prevent childhood over ... Read more

Ozempic® approved in the US for CV risk reduction in people with type 2 diabetes ... Read more

Novo Nordisk A/S – Share repurchase programme ... Read more

Financial calendar 2020 ... Read more

Novo Nordisk A/S – Share repurchase programme ... Read more

Financial statement for the full year of 2019,

Cut-off date for shareholders' proposals in connection with the Annual General Meeting (AGM),

Annual General Meeting, Copenhagen

Silent period,